Literature DB >> 14645684

A new principle for tight junction modulation based on occludin peptides.

Staffan Tavelin1, Kei Hashimoto, John Malkinson, Lucia Lazorova, Istvan Toth, Per Artursson.   

Abstract

The aim of this study was to investigate whether peptides from the extracellular loops of the tight junction protein occludin could be used as a new principle for tight junction modulation. Peptides of 4 to 47 amino acids in length and covering the two extracellular loops of the tight junction protein occludin were synthesized, and their effect on the tight junction permeability in Caco-2 cells was investigated using [14C]mannitol as a para-cellular marker. Lipopeptide derivatives of one of the active occludin peptides (OPs), synthesized by adding a lipoamino acid containing 14 carbon atoms (C14-) to the N terminus of the peptide, were also investigated. Peptides corresponding to the N terminus of the first extracellular loop of occludin increased the permeability of the tight junctions without causing short-term toxicity. However, the peptides had an effect only when added to the basolateral side of the cells, which could be partly explained by degradation by apical peptidases and aggregate formation. By contrast, the lipopeptide C14-OP90-103, which protects the peptide from degradation and aggregation, displayed a rapid apical effect. The l- and d-diastereomers of C14-OP90-103 had distinctly different effects. The d-isomer, which releases intact OP90-103 from the lipoamino acid, displayed a rapid and transient increase in tight junction permeability. The l-isomer, which releases OP90-103 more rapidly, gave a more sustained increase in tight junction permeability. In conclusion, C14-OP90-103 represents a prototype of a new class of tight junction modulators that act on the extracellular domains of tight junction proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645684     DOI: 10.1124/mol.64.6.1530

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  36 in total

1.  A human claudin-1-derived peptide inhibits hepatitis C virus entry.

Authors:  Youhui Si; Shufeng Liu; Xiuying Liu; Jana L Jacobs; Min Cheng; Yuqiang Niu; Qi Jin; Tianyi Wang; Wei Yang
Journal:  Hepatology       Date:  2012-06-11       Impact factor: 17.425

Review 2.  Claudin and occludin expression and function in the seminiferous epithelium.

Authors:  Carla M K Morrow; Dolores Mruk; C Yan Cheng; Rex A Hess
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

3.  Cytoskeleton reorganization and ultrastructural damage induced by gliadin in a three-dimensional in vitro model.

Authors:  Ersilia Dolfini; Leda Roncoroni; Luca Elli; Chiara Fumagalli; Roberto Colombo; Simona Ramponi; Fabio Forlani; Maria Teresa Bardella
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 4.  Critical role of tight junctions in drug delivery across epithelial and endothelial cell layers.

Authors:  L González-Mariscal; P Nava; S Hernández
Journal:  J Membr Biol       Date:  2005-09       Impact factor: 1.843

5.  Epithelial barrier modulation by a channel forming peptide.

Authors:  Suma Somasekharan; Robert Brandt; Takeo Iwamoto; John M Tomich; Bruce D Schultz
Journal:  J Membr Biol       Date:  2008-03       Impact factor: 1.843

Review 6.  Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers.

Authors:  Marlyn Laksitorini; Vivitri D Prasasty; Paul K Kiptoo; Teruna J Siahaan
Journal:  Ther Deliv       Date:  2014-10

7.  Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats.

Authors:  Xian-kun Tu; Wei-zhong Yang; Ri-sheng Liang; Song-sheng Shi; Jian-ping Chen; Chun-mei Chen; Chun-hua Wang; Hai-shu Xie; Yan Chen; Long-qiang Ouyang
Journal:  Neurochem Res       Date:  2011-06-17       Impact factor: 3.996

8.  Limb Ischemic Perconditioning Attenuates Blood-Brain Barrier Disruption by Inhibiting Activity of MMP-9 and Occludin Degradation after Focal Cerebral Ischemia.

Authors:  Changhong Ren; Ning Li; Brian Wang; Yong Yang; Jinhuan Gao; Sijie Li; Yuchuan Ding; Kunlin Jin; Xunming Ji
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

9.  Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia.

Authors:  Wenlan Liu; Jill Hendren; Xu-Jun Qin; Jiangang Shen; Ke Jian Liu
Journal:  J Neurochem       Date:  2009-02       Impact factor: 5.372

10.  A key claudin extracellular loop domain is critical for epithelial barrier integrity.

Authors:  Randall J Mrsny; G Thomas Brown; Kirsten Gerner-Smidt; Andre G Buret; Jon B Meddings; Clifford Quan; Michael Koval; Asma Nusrat
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.